FFA
VKTX icon

Farther Finance Advisors’s Viking Therapeutics VKTX Stock Holding History

Farther Finance Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$469K Sell
14,373
-798
-5% -$27.6K ﹤0.01% 1640
2026
Q2 		$592K Buy
15,171
+1,584
+12% +$51.2K ﹤0.01% 1441
2026
Q1 		$448K Sell
13,587
-2,170
-14% -$69.7K ﹤0.01% 1485
2025
Q4 		$554K Buy
15,757
+13,730
+677% +$486K 0.01% 1233
2025
Q3 		$53.3K Sell
2,027
-14
-0.7% -$418 ﹤0.01% 2402
2025
Q2 		$54.1K Buy
2,041
+1,737
+571% +$45.7K ﹤0.01% 2100
2025
Q1 		$7.27K Buy
304
+124
+69% +$3.92K ﹤0.01% 2889
2024
Q4 		$7.24K Sell
180
-131
-42% -$7.47K ﹤0.01% 2510
2024
Q3 		$19.7K Buy
311
+211
+211% +$12.4K ﹤0.01% 2087
2024
Q2 		$5.53K Buy
100
+78
+355% +$5.11K ﹤0.01% 2356
2024
Q1 		$1.75K Buy
+22
New +$979 ﹤0.01% 2542

Other funds holding VKTX

MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
NWMP
Noble Wealth Management PBC Greenwood Village, Colorado $223M AUM 7.64% 1-Year Est. Return
BFS
Burkett Financial Services Rock Hill, South Carolina $331M AUM 14.93% 1-Year Est. Return
GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return
PP
Paladin Partners Hartland, Wisconsin $162M AUM 13.31% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $937M AUM 18.56% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM

Farther Finance Advisors's VKTX Position: Q3 2026 in Review

Farther Finance Advisors reduced its Viking Therapeutics (VKTX) stake by 5.3% in Q3 2026, selling an estimated $27.6K and leaving 14,373 shares worth $469K. The position accounts for ﹤0.01% of the portfolio, ranked #1640.

Farther Finance Advisors first reported a position in VKTX in Q1 2024 and has held it in 11 quarters since. The position peaked at $592K in Q2 2026. 11 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.

  • Farther Finance Advisors held 14,373 shares of Viking Therapeutics worth $469K as of Q3 2026.
  • Farther Finance Advisors sold 798 Viking Therapeutics shares in Q3 2026, an estimated $27.6K.
  • Viking Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1640 holding.
  • Farther Finance Advisors first reported a position in Viking Therapeutics in Q1 2024 and has held it in 11 quarters since.
  • Farther Finance Advisors's Viking Therapeutics position peaked at $592K in Q2 2026.
  • 11 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.